PRP

A consensus of experts identified seven recommended interventions for AGA, including oral and topical finasteride, dutasteride, and minoxidil, while identifying 17 interventions that are not recommended.

Various over-the-counter, prescription, and procedural treatments successfully promote hair growth, suggesting that a multifaceted, individualized approach is most effective.

Various treatments including 5-alpha reductase inhibitors, oral minoxidil, and PRP show efficacy, though evidence for some newer or non-pharmacological methods remains limited.

Chemotherapy-induced alopecia affects approximately 65% of patients; current FDA-cleared prevention is limited to scalp cooling, while regrowth options include minoxidil, PBMT, and PRP.

Standard treatments like topical minoxidil and oral finasteride are established, while newer modalities like PRP, LLLT, and oral minoxidil show encouraging results but lack standardized protocols.

The review discusses various promising topical, oral, and energy-based therapies, noting growing evidence for their efficacy in treating hair loss.

The review outlines various current and emerging therapies for hair loss, including pharmacological agents, devices, and cellular therapies.

Microneedling serves as an effective adjunct therapy for androgenic alopecia when paired with minoxidil, growth factors, or PRP, and shows promise as a standalone therapy for alopecia areata.

The review indicates that PRP can be used effectively for the treatment of hair loss, though the exact mechanism of action is not yet fully understood.

Traditional treatments like corticosteroids and minoxidil have limited efficacy and high recurrence rates, while new strategies like JAK inhibitors and biologics are emerging.

The review identifies MSC implantation, MSC-derived secretome, and PRP as promising regenerative treatment options for alopecia, though further clinical application strategies are needed.

Current treatments for alopecia areata lack proven long-term effectiveness for all patients and are prone to relapse. JAK-STAT inhibitors and PRP are identified as promising future therapies.

The review outlines various FDA-approved and non-FDA-approved therapies for AGA, emphasizing that treatment selection must balance efficacy, side effects, compliance, and cost.

PRP shows promise for promoting hair regrowth and improving skin quality, particularly when combined with microneedling or laser therapies, although standardized treatment protocols are lacking.

Finasteride and minoxidil can halt disease progression but only yield partial hair regrowth; early initiation improves outcomes, and PRP may be considered for patients unresponsive to medical therapy.

Hair transplant surgery is effective for creating natural-appearing hair in men, though optimal harvesting techniques and adjunctive therapies remain subjects of debate.